Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2003
06/05/2003US20030103948 Streptavidin expressed gene fusions and methods of use thereof
06/05/2003US20030103934 Comprises polyethylene glycol-bound ligand having binding affinity to a cell surface receptor or cell surface protein, wherein ligand avoids and/or inhibits cellular internalization
06/05/2003US20030103933 Proteins stabilized with polysaccharide gums
06/05/2003US20030103924 Mixture containing polymeric carrier
06/05/2003US20030102109 Cooling apparatus
06/05/2003US20030101995 Dry powder inhalation system for transpulmonary administration
06/05/2003CA2486924A1 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization
06/05/2003CA2468878A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their productionor generation
06/05/2003CA2468548A1 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
06/05/2003CA2468501A1 T-cell epitodes in carboxypeptidase g2
06/05/2003CA2468494A1 Pharmaceutical compositions and methods for administering ep2 receptor selective agonists
06/05/2003CA2468390A1 Treatment of wounds and compositions employed
06/05/2003CA2468320A1 Methods for treating cancer using a combination of a tumor-derived dendritic cell inhibitory factor antagonist and a toll-like receptor agonist
06/05/2003CA2468250A1 Pharmaceutical composition for nasal absorption
06/05/2003CA2468246A1 Increasing electro-gene transfer of nucleic acid molecules into host tissue
06/05/2003CA2468187A1 Peptides with growth inhibitory action
06/05/2003CA2468135A1 Ginger extract preparation
06/05/2003CA2468016A1 Humanized collagen antibodies and related methods
06/05/2003CA2467677A1 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
06/05/2003CA2466863A1 Formulations for oral administration of cromolyn sodium
06/05/2003CA2466807A1 Pharmaceutical formulations comprising indolinone derivatives
06/05/2003CA2466677A1 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus
06/05/2003CA2466039A1 Improved synthesis of polyanhydrides
06/05/2003CA2465846A1 Targeted therapeutics and uses thereof
06/05/2003CA2460785A1 Process for preparing chewing gum containing a nutritional supplement
06/04/2003EP1316562A2 Composition comprising a covalent polyethylene glycol (PEG)-protein adduct
06/04/2003EP1316318A2 Method of transducing a protein into cells
06/04/2003EP1316317A1 Hydrosoluble mixtures of cyproterone and/or an ester of it, processes to obtain them and uses thereof
06/04/2003EP1316316A1 Preparations for oral administration
06/04/2003EP1316310A1 Ophthalmic composition comprising a histidine derivative for healing asthenopia
06/04/2003EP1316309A1 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315777A2 Degradable polyacetal polymers
06/04/2003EP1315756A2 Electroprocessed fibrin-based matrices and tissues
06/04/2003EP1315755A1 Anti-angiogenic peptides
06/04/2003EP1315749A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport
06/04/2003EP1315742A1 Amino acid substitution mutants of interleukin 13
06/04/2003EP1315739A2 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof
06/04/2003EP1315729A1 Compounds in the form of homodimeric, heterodimeric and/or homo and heteromultimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterasis-mediated diseases or dysfunction
06/04/2003EP1315699A2 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
06/04/2003EP1315523A1 Vp22 protein / nucleic acid aggregates, uses thereof
06/04/2003EP1315522A2 Calycins
06/04/2003EP1315521A2 Method for improving the efficacy of artificial insemination of non-human animals
06/04/2003EP1315513A2 "pseudo"-native chemical ligation
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP1315511A2 Synthetic erythropoiesis stimulating proteins
06/04/2003EP1315509A2 Treatment of drug resistant organisms with nitric oxide
06/04/2003EP1315506A2 Phospholipid derivatives of valproic acid and mixtures thereof
06/04/2003EP1315502A1 Method for treating erectile dysfunction and increasing libido in men
06/04/2003EP1315501A1 Alpha v integrin receptor antagonists
06/04/2003EP1315500A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
06/04/2003EP1315493A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
06/04/2003EP1315487A2 Flavoring systems for pharmaceutical compositions and methods of making such compositions
06/04/2003EP1315484A1 Taxane-based compositions and methods of use
06/04/2003EP1315483A2 Combined estrogen blockade of the breast with exemestane and raloxifene
06/04/2003EP1315482A2 Water-dispersible encapsulated sterols
06/04/2003EP1315481A1 Medicament for treating intestinal diseases
06/04/2003EP1315480A2 "slow release" pharmaceutical compositions comprising lithium carbonate
06/04/2003EP1315479A1 Pectin film compositions
06/04/2003EP1315477A1 Dry-powder film coating composition and method of preparation
06/04/2003EP1315476A2 Nitric oxide-producing hydrogel materials
06/04/2003EP1315475A1 Lung surfactant compositions with dynamic swelling behaviour
06/04/2003EP1315423A1 A thermo-stable bio-matrix
06/04/2003EP1253950B1 Sterile water generator and decontamination system
06/04/2003EP1222018B1 Use of galactomannans as an emulsifying agent
06/04/2003EP1207857B1 Ciprofloxacin containing pharmaceutical composition and process for the preparation thereof
06/04/2003EP1206248B1 Controlled-release sedative-hypnotic compositions and methods related thereto
06/04/2003EP1196444B1 Extendin-4 conjugates and their medical use
06/04/2003EP1159061A4 Chemical method for making pyrithione particle dispersions
06/04/2003EP1119347A4 Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide
06/04/2003EP1076671B1 Non cross-linked block polyetherester, preparation and uses
06/04/2003EP1030676A4 Bonding of cartilaginous matrices using isolated chondrocytes
06/04/2003EP0977557B1 Pellet-type formulation intended for treating the intestinal tract
06/04/2003EP0969821B1 Pellets having a core coated with an antifungal and a polymer
06/04/2003EP0927031B1 Pharmaceutical preparation containing nimesulide for oral administration
06/04/2003EP0920869B1 Stable external preparations containing acetylsalicylic acid
06/04/2003EP0909175B1 Non-aqueous protic peptide formulations
06/04/2003EP0904098B1 Compositions comprising antifungal agent and acetate buffer
06/04/2003EP0885010B1 Intercellular adhesion molecule powder formulation
06/04/2003EP0858329B1 Novel stable liquid paracetamol compositions, and method for preparing same
06/04/2003EP0858324B1 Process for aqueous granulation of clarithromycin
06/04/2003EP0744941B1 Process for preparing fine particle pharmaceutical formulations
06/04/2003EP0689438B1 Pharmaceutical compositions for intranasal administration of apomorphine
06/04/2003EP0670730B1 Fusion protein comprising two tumor necrosis factor receptors
06/04/2003EP0656037B1 Metal-mediated cross-coupling with ring-metalated porphyrins
06/04/2003CN1422163A Formulation solubilizing water-insoluble agents and preparation method thereof
06/04/2003CN1422158A Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
06/04/2003CN1422154A The treatment of respiratory diseases
06/04/2003CN1422151A Pharmaceutical composition comprising fluvastatin
06/04/2003CN1422149A Pharmaceutical compositions
06/04/2003CN1422148A Method for treating dry eye
06/04/2003CN1422142A Pharmaceutical composition
06/04/2003CN1422121A Protein stabilised emulsions
06/04/2003CN1421206A Medical composition
06/04/2003CN1110509C The use of copolymers of N-vinylpyrrolidone in preparation of water-insoluble substances
06/04/2003CN1110457C Production process of pharmaceutic water and its equipment
06/04/2003CN1110304C Slow-release medicine composition for oral administration containing nifedipine as active substance
06/04/2003CN1110301C Therapeutic preparation for inhalation
1 ... 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 ... 1712